Ethiopian Food and Drug Authority

What Ethiopian Food and Drug Authority does

The Ethiopian Food and Drug Authority (EFDA) is an autonomous federal regulatory agency under Ethiopia's Ministry of Health, established as an independent body under Proclamation No. 1263/2021 (with roots in Proclamation 176/1999 and successor proclamations 661/2009, 1263/2021, and regulations 531/2023). It is mandated to ensure the safety, quality, and efficacy of medicines, food, medical devices, cosmetics, tobacco, and blood/blood products consumed or distributed in Ethiopia. Its core functions span market authorization, facility licensing, import/export control, market surveillance and inspection, quality control testing, clinical trial authorization, pharmacovigilance, and product promotion/advertising control.

EFDA's core digital infrastructure is the Electronic Regulatory Information System (eRIS), comprising three open-source modules — i-Import, i-Register, and i-License — built in collaboration with JSI (John Snow, Inc.) and funded by USAID and the Bill & Melinda Gates Foundation. It is complemented by a GS1-standards-based Pharmaceutical Traceability System and a Food Rapid Alert system for safety notifications. The authority holds ISO/IEC 17025 (laboratory competence) accreditation, ISO/IEC 17020 (inspection body accreditation), and ISO 13485 (medical device quality management) certifications across multiple labs and branches.

EFDA's revenue model combines federal government budget allocations with regulatory service fees and administrative fines. Fee schedules are codified under Regulation No. 531/2023, covering market authorization applications, product registration, import/export permits, facility licensing, and analytical testing. The authority serves a wide base of regulated entities — importers, exporters, manufacturers, wholesalers, retailers, healthcare facilities, and clinical trial sponsors — alongside the Ethiopian public. Operations are delivered through approximately 501–1,000 staff organized across three sector pillars (Food; Medicine; Medical Devices) and seven regional branch offices (Adama, Hawassa, Mekelle, Bahir Dar, Dire Dawa, Jimma, and Dessie).

Name

Ethiopian Food and Drug Authority

Legal name

Ethiopian Food and Drug Authority

Website

https://efda.gov.et

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

501–1,000 employees

Short description

EFDA is Ethiopia's autonomous federal regulatory authority under the Ministry of Health, overseeing the safety, quality, and efficacy of medicines, food, medical devices, cosmetics, and tobacco products through licensing, inspection, market surveillance, and electronic regulatory systems (eRIS).

Ownership category

akta.pro rank

Product category

Pharmaceutical and Food Regulatory Services

NAICS

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (92615)

akta.pro primary industry

Drug Regulators (Human Pharmaceuticals) (HLAJADAA)

akta.pro secondary industries

Supplier Approval, Verification & Food Safety Risk Management (GFSI-aligned) (AFALADAH), Regulatory Submissions, Registrations & Facility Approvals (FDA/USDA/EU) (AFALADAD), Import/Export & Border Compliance Support (FSVP, Prior Notice, Health Certificates) (AFALADAE), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Pharmaceutical regulation
• Food safety oversight
• Medical device authorization
• Market authorization services
• Drug import licensing

Headquarters

HQ city

Addis Ababa

HQ country

Ethiopia

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Regulatory Service Fees: EFDA collects service fees for regulatory activities including market authorization, licensing, inspection, and other regulatory services as mandated under Regulation No. 531/2023 and the Council of Ministers regulations.
2. Administrative Fines: The authority imposes fines as per regulations for violations of regulatory laws, non-compliance, and illegal activities related to regulated products.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

EFDA is Ethiopia's federal regulatory authority that regulates the safety, quality, and efficacy of food, medicines, medical devices, cosmetics, tobacco, and blood products. It delivers market authorization, facility licensing, inspection, quality control testing, clinical trial authorization, pharmacovigilance, and product promotion control through its Electronic Regulatory Information System (eRIS)—an open-source platform spanning i-Import, i-Register, and i-License—as well as a GS1-based Pharmaceutical Traceability System and a Food Safety Alert Application.

Product overview

EFDA operates as a regulatory authority offering a platform of electronic regulatory systems and regulatory services. The core digital infrastructure consists of the Electronic Regulatory Information System (eRIS) housing three interconnected modules: i-Import for import permit applications, i-Register for market authorization and product registration, and i-License for facility licensing. These open-source systems, developed with international collaboration and funding support, work together to provide end-to-end visibility along Ethiopia's pharmaceutical supply chain. Additional offerings include the Pharmaceutical Traceability System using GS1 standards for track-and-trace capabilities, the Food Safety Alert Application for rapid public communication, and traditional regulatory services including quality control testing, clinical trial authorization, vigilance (adverse event monitoring), and market surveillance. The organization regulates food, medicines, medical devices, cosmetics, tobacco, and other health products.

Differentiator

Problem solved

Functional benefit

Products and services

• i-Import Electronic Import System Open-source online application that allows importers to apply for and receive permits to import medicines online, while enabling EFDA staff to manage and process these applications electronically. Used by pharmaceutical importers seeking import permits for the Ethiopian market.
• i-Register Product Registration System Public domain web-based management information system that automates medical product registration, application submission, screening, review, and market authorization processes, including new product registration, variations, and re-authorization. Used by pharmaceutical manufacturers seeking market authorization in Ethiopia.
• i-License Facility Licensing System Web-based management information system that automates facility information for importers, exporters, wholesalers and manufacturers, including online applications for certificates of competency, renewals, and changes to facility information. Used by regulated product facilities requiring EFDA licensing.
• Electronic Regulatory Information System (eRIS) Central open-source platform housing i-Import, i-Register, and i-License applications, providing end-to-end visibility along Ethiopia's pharmaceutical supply chain with standard terminologies (INN, ATC) and workforce management capabilities. Used by regulated entities and EFDA staff.
• Pharmaceutical Traceability System Track and trace system for pharmaceutical products using GS1 standards (GTIN, SSCC, GLN) and 2D DataMatrix barcodes to enhance visibility of product movement from manufacturer to healthcare provider, prevent counterfeit medicines, and improve recall processes. Used by pharmaceutical manufacturers, distributors, and regulators.
• Food Safety Alert Application Technology-enabled application launched to provide food safety alerts to the public, enhancing food safety monitoring and rapid communication of food safety issues. Used by consumers, food businesses, and public health stakeholders in Ethiopia.
• Market Authorization and Product Registration Service Regulatory service for registering products and issuing market authorization certificates for medicines, medical devices, food, and cosmetics, managed through the i-Register system. Used by domestic and international manufacturers of regulated products.
• Licensing of Premises Service Regulatory service for issuing and renewing licenses for importers, exporters, wholesalers, and manufacturers of regulated products, managed through the i-License system. Used by regulated product facilities requiring EFDA licensing.
• Market Surveillance and Inspection Service Regulatory oversight activities including on-site inspection of establishments and post-market surveillance of food, medicines, medical devices, cosmetics, and tobacco products. Used by manufacturers, importers, wholesalers, retailers, and healthcare facilities across Ethiopia's seven EFDA branch territories.
• Quality Control Testing Service ISO/IEC 17025-accredited laboratory testing services for food, medicines, and medical devices to ensure quality and safety of regulated products, including recently expanded testing of drug samples for African countries. Used by manufacturers, importers, and African regulatory partners.
• Clinical Trial Authorization Service Evaluation and authorization of clinical trial requests, with monitoring and inspection to ensure compliance with authorization and good clinical trial practices. Used by pharmaceutical sponsors, researchers, and contract research organizations conducting clinical trials in Ethiopia.
• Vigilance (Pharmacovigilance and Adverse Event Reporting) Service Safety monitoring of regulated products including adverse event reporting and surveillance, with the e-Reporting of ADR system for adverse drug reaction reporting and dedicated pharmacovigilance centers. Used by healthcare professionals, manufacturers, and patients reporting adverse reactions.
• Medicine and Device Promotion Control Service Regulatory control over promotion and advertising of medicines and medical devices to ensure ethical marketing practices and accurate product claims. Used by pharmaceutical and medical device companies promoting products to Ethiopian healthcare professionals and consumers.

Quantifiable outcome

• WHO Maturity Level 3 attained in medicine regulation
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered minor, core and regional.

• Empower Swiss SARLminorStrategic or Co-development Partner · 1 March 2025Ethiopian Food and Drug Authority and Empower Swiss SARL signed a memorandum of understanding (MOU) for collaboration.
• EPPADminorStrategic or Co-development Partner · 1 March 2025EFDA and EPPAD signed a historic collaboration agreement for joint regulatory activities.
• U.S. Pharmacopeia (USP) / PQM PluscoreStrategic or Co-development Partner · 21 October 2024EFDA, AHRI, and USP/PQM Plus collaborate with local pharmaceutical manufacturers to implement the National Bioequivalence Roadmap, enhancing local pharmaceutical manufacturing quality and regulatory capacity.
• Bahrain AuthoritiesminorStrategic or Co-development Partner · 24 March 2024Ethiopian Food and Drug Authority collaborated with Bahrain on drug production control systems, sharing regulatory expertise.
• Ministry of Trade and Regional IntegrationcoreStrategic or Co-development Partner · 1 January 2024EFDA and Ministry of Trade and Regional Integration partnered to launch online services, enhancing regulatory service delivery through electronic systems.
• GHSC-PSM (Global Health Supply Chain Program)coreStrategic or Co-development Partner · 1 January 2024EFDA and GHSC-PSM hosted Pharmacovigilance and Vaccine Safety Review meetings with key stakeholders in Adama to strengthen vaccine safety monitoring.
• Media AuthorityminorStrategic or Co-development Partner · 1 January 2024EFDA and Media Authority collaborated to urge ethical standards in food and health product promotion across media platforms.
• National Tobacco Control CommitteecoreStrategic or Co-development Partner · 1 January 2024EFDA signed a joint agreement with National Tobacco Control Committee members to coordinate implementation of WHO Framework Convention on Tobacco Control.
• IGAD (Intergovernmental Authority on Development)regionalStrategic or Co-development Partner · 1 January 2024IGAD regulatory authorities convened in Addis Ababa with EFDA to strengthen regional harmonization of pharmaceutical regulation.
• John Snow, Inc. (JSI)coreStrategic or Co-development PartnerJSI collaborated with EFDA to design and implement i-Import, i-Register, and i-License electronic regulatory systems. JSI worked with EFDA to develop online platforms for import permitting, market authorization, and facility licensing processes.
• WHO (World Health Organization)coreStrategic or Co-development PartnerEFDA works with WHO for regulatory guidelines, standards, and maturity level assessment. Adopted WHO TRS No.1052, 2024, Annex 4; TRS No. 1025, 2020, Annex 13 for quality management systems.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Tanzania Medicines and Medical Devices Authority (TMDA): Tanzania's national regulator for medicines, medical devices, and food. Comparable as an East African peer regulator that has achieved WHO ML3 and collaborates with EFDA through IGAD on regional harmonization.
• National Agency for Food and Drug Administration and Control (NAFDAC): Nigeria's federal regulator of food, drugs, medical devices, cosmetics, and chemicals. Closely comparable as a large African national regulator with overlapping product scope, electronic registration systems, and a similar mandate to drive local manufacturing quality.
• Pharmacy and Poisons Board (PPB) Kenya: Kenya's national medicines regulatory authority. Comparable in mandate (drug registration, licensing, pharmacovigilance) and operates in the same East African regulatory harmonization framework as EFDA.
• South African Health Products Regulatory Authority (SAHPRA): South Africa's national medicines and medical devices regulator. Comparable in function (market authorization, licensing, vigilance) and is the most advanced African regulator, making it both a benchmark and a regional competitor for EFDA's pan-African testing ambitions.
• National Drug Authority (NDA) Uganda: Uganda's national drug and food regulator. Comparable as a smaller East African national regulator collaborating with EFDA through IGAD on harmonization of pharmaceutical regulation in the region.

Broad incumbents

• European Medicines Agency (EMA): The EU-wide medicines regulator. Comparable as a medicines-focused regulator with mature electronic submission and pharmacovigilance systems that EFDA's eRIS architecture has been benchmarked against.
• U.S. Food and Drug Administration (FDA): The U.S. federal regulator of food, drugs, medical devices, cosmetics, and tobacco. Most directly comparable in scope (multi-product national regulator) and serves as the global benchmark for maturity assessments like the WHO ML rating that EFDA has now achieved.
• UK Medicines and Healthcare products Regulatory Agency (MHRA): The UK's regulator for medicines, medical devices, and blood. Comparable in scope and in operating mature electronic regulatory and traceability systems; serves as a reference architecture for newer regulators.

Others

• U.S. Pharmacopeia (USP) / PQM Plus: Quality standards organization and donor-funded technical assistance provider. Comparable as a partner/peer working on local pharma manufacturing quality and bioequivalence in Ethiopia, and as an adjacent quality infrastructure provider.
• World Health Organization (WHO) - Regulatory Systems Strengthening: Not a regulator but the standard-setter and assessor of national regulatory authorities. Directly comparable as the entity that defines the ML framework and benchmarks (e.g., ML3) against which EFDA is measured; also a partner in capacity building.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/EfdaMedia
• YouTubeyoutube.com/@FDAEthiopiaMedia
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/ethiopian-food-and-drug-authority

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ethiopian Food and Drug Authority